Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro.
D002452:Cell Count; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D015870:Gene Expression; D006801:Humans; D010190:Pancreatic Neoplasms / Q000473:pathology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024681:Potassium Channels, Calcium-Activated / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
D026902:Potassium Channel Blockers; D024681:Potassium Channels, Calcium-Activated